7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Ironwood Pharmaceuticals, Inc
(NASDAQ:IRWD) 

IRWD stock logo

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chroni...

Founded: 1998
Full Time Employees: 317
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic

Share this website to your friends
Ironwood Pharmaceuticals Days Payable Outstanding ttm (DPO)
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0259.22518.45777.671,036.91,296.121,555.351,814.57
Ironwood Pharmaceuticals Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 016.5233.0349.5566.0682.5899.09115.61
Ironwood Pharmaceuticals Days Inventory Outstanding ttm (DIO)
202109 202110 202111 202112 202201 202202 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00000000
Ironwood Pharmaceuticals Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.30.60.91.21.511.812.11
Ironwood Pharmaceuticals Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.30.60.91.21.51.812.11
Ironwood Pharmaceuticals Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.681.372.052.743.424.114.79
Ironwood Pharmaceuticals P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.751.512.263.013.764.525.27
Ironwood Pharmaceuticals (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.39-0.431.533.495.447.49.3611.32
Ironwood Pharmaceuticals P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -6.98-5.53-4.07-2.62-1.160.31.753.21
No extra charts and metrics for this ticker.